Repulsive guidance molecule (RGM) is a membrane-bound protein originally isolated as a guidance molecule for retinal axons. Three RGM isoforms (RGMa-RGMc) exist in vertebrates. We showed previously that RGMa is a cell-survival factor in the neuroepithelium of chick embryos that suppresses the proapoptotic activity of its receptor neogenin. In the present study, we performed gain-and loss-offunction analysis of RGMa in chick embryos to further investigate RGMa function. We found that RGMa overexpression promotes neuronal differentiation, whereas RGMa small interference RNA represses it. Similar experiments conducted at later developmental stages using retroviral vectors reveal that perturbation of RGMa expression disturbs the retinotectal projection. Our work provides the first evidence for a role for RGMs in axon guidance in vivo. In addition, these results suggest that RGMa exerts multiple functions during neural development.
Introduction
In vertebrates, retinal axons make connections in a topographic manner (Sperry, 1963; McLaughlin et al., 2003) . Temporal retinal axons project to the anterior tectum and nasal axons to its posterior part. Sperry (1963) proposed that the development of this topographic projection is governed by ligands and receptors expressed in complementary gradients in the retina and tectum. Accordingly, biochemical analysis revealed that retinal axons are guided by repulsive glycosylphosphatidylinositol-anchored proteins highly expressed in the posterior tectum (Stahl et al., 1990) . ephrin-A2 and ephrin-A5 were the first molecules identified as topographic guidance molecules in this system (Cheng et al., 1995; Drescher et al., 1995) , recently followed by repulsive guidance molecule isoform a (RGMa) (Monnier et al., 2002) . However, there is so far no direct evidence that RGMa guides retinal axons in vivo, and the analysis of RGMa-deficient mice suggested that RGMa does not guide retinal axons (Niederkofler et al., 2004) .
RGMa is expressed in the neural tube before the appearance of retinal axons , suggesting that it exerts additional roles in CNS development . Accordingly, RGMa knock-out mice show defects in neural tube closure (Niederkofler et al., 2004) . Recently, a transmembrane protein, neogenin, has been identified as a receptor for RGMa mediating its repulsive activity (Rajagopalan et al., 2004) . Neogenin was also shown to be a dependence receptor (Mehlen and Thibert, 2004) inducing apoptosis when unoccupied by RGMa .
We performed here gain-and loss-of-function analysis of RGMa in chick embryos to show that RGMa controls neuronal proliferation, differentiation, and axon guidance in addition to neuronal survival.
Materials and Methods
Expression constructs and in ovo electroporation. Most expression constructs, including RGMa small interfering RNA (siRNA), were described previously . A second RGMa siRNA (RGMa siRNA-2; 5Ј-AATGCGTGGAGCAGAAAGTGT-3Ј) was also designed. For long-term expression, RGM siRNAs and a control siRNA (a scramble form of RGMa siRNA; 5Ј-AATCTCGTAGTGTGCTCTATC-3Ј) were excised from pSilencer together with the U6 promoter and subcloned into RCASBP(B) vectors (Hughes et al., 1987; Fekete and Cepko, 1993) . Hamburger and Hamilton stage 10 (HH10) to HH11 (Hamburger and Hamilton, 1951 ) chick embryos were electroporated as described previously (Funahashi et al., 1999) or using tungsten needles, with the following constructs: pMiw-RGMa (3.0 mg/ml), pMiw-RGMa-green fluorescent protein (GFP) (3.0 mg/ml), pcDNA-human neogenin (3.0 mg/ml), pSilencer-RGMa siRNA (1.5 mg/ml), pSilencer-neogenin siRNA (1.5 mg/ ml), pSilencer-control siRNA (1.5 mg/ml), pBabe-p35 (1.0 mg/ml), RCASBP(B)-RGMa (2.0 mg/ml), RCASBP(B)-alkaline phosphatase (AP) (2.0 mg/ml), RCASBP(B)-RGMa siRNA (1.0 mg/ml), RCASBP(B)-RGMa siRNA-2 (1.0 mg/ml), and RCASBP(B)-control siRNA (1.0 mg/ ml). GFP expression vector ( pMiwIII-GFP, 0.5 mg/ml) was coelectroporated to check the electroporation efficiency.
Bromodeoxyuridine incorporation experiments. Bromodeoxyuridine (BrdU) (10 mM) was injected in chick embryos as described previously (Matsunaga et al., 2002) . In situ hybridization. Probes and procedures for in situ hybridization on whole-mount embryos and sections were described previously (Matsunaga et al., 2000; Marillat et al., 2002) .
Immunohistochemistry. Whole-mount immunostaining was performed as described previously (Chédotal et al., 1995) . Embryos were incubated with mouse anti-␤III-tubulin antibody (1:2000, TuJ1; Babco, Richmond, VA) or rabbit anti-GFP antibody (Invitrogen, Carlsbad, CA). Embryos were cut partially or totally along the dorsal midline and ventral midline and then flat mounted. Immunostaining on sections was performed as described previously (Matsunaga et al., 2001) . gag was visualized using rabbit antigag polyclonal antibody (1:200; kindly provided by Dr. T. Jaffredo, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7622, Paris, France) or mouse monoclonal antibody (1:100; clone AMV-3C2; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA). Neogenin expression was detected using a rabbit polyclonal neogenin antibody (1:100; Santa Cruz Biotechnology, Santa Cruz, CA).
Dil labeling of retinal axons. Retinal fibers were labeled with DiI (Invitrogen) and analyzed as described previously (Itasaki and Nakamura, 1996) . A small DiI crystal was inserted into the dorsotemporal retina at embryonic day 15 (E15) to E16 (Nakamoto et al., 1996) . After examination of DiI-labeled axons trajectory, 150-m-thick sections of the tectum were made with a vibratome (Leica, Nussloch, Germany) and counterstained with Hoechst (Sigma, St. Louis, MO).
Results

RGMa overexpression promotes neuronal differentiation
Neuronal differentiation in the hindbrain and midbrain starts at approximately HH11ϩ and HH14, respectively (Ché-dotal et al., 1995; Eickholt et al., 2001 ). In the midbrain, neurons differentiate in an anterior-to-posterior manner (LaVail and Cowan, 1971) . RGMa expression starts before the onset of neuronal differentiation and is well correlated with the timing of neuronal differentiation particularly in the midbrain and data not shown), suggesting that RGMa might control neuronal differentiation. To test this possibility, we overexpressed RGMa in the diencephalon and myelencephalon of HH10 -11 embryos. Similar results were obtained with pMiw-RGMa or RCASBP(B)-RGMa expression vectors.
We first found that, 48 h after electroporation, the size of the neural tube was reduced on the experimental side ( Fig.  1 A-C) . Because RGMa overexpression does not influence cell death , we tried to determine whether neuronal proliferation was affected. At 24 h after electroporation, the number of BrdU-labeled cells was significantly reduced in the midbrain (Ϫ27.26 Ϯ 1.48%; n ϭ 4 of 4) and hindbrain (Ϫ44.64 Ϯ 13.77%; n ϭ 4 of 4) (Figs. 1 D-F, 2H), indicating that RGMa reduced cell proliferation. This reduction was transient and was not detected when BrdU was injected 48 h after electroporation (data not shown). Next, we overexpressed RGMa or an RGMa-GFP fusion protein and examined whether RGMa also influenced neuronal differentiation using immunostaining for ␤-tubulin. We mainly examined the rhombencephalon of HH15 chick embryos because, at this stage, it contains a limited number of neurons. At 15 h after RGMa electroporation, the number of ␤-tubulin-positive cells was increased on the experimental side in the midbrain (ϩ88.40 Ϯ 14.94%; n ϭ 4 of 5) and hindbrain (ϩ40.11 Ϯ 7.98%; n ϭ 6 of 8) (Figs. 1G, 2I), indicating that RGMa promoted neuronal differentiation. ␤-Tubulinpositive neurons were always observed around GFP-positive cells (Fig. 1 H, I ), suggesting that RGMa functions as a ligand and stimulates neuronal differentiation around RGMa-expressing cells. Moreover, we performed loss-of-function experiments by expressing siRNA (Katahira and Nakamura, 2003) for RGMa . BrdU incorporation experiments revealed that suppression of RGMa expression had little effects on cell proliferation (ϩ7.14 Ϯ 4.20%; n ϭ 7 of 8) (Fig. 2 H) . In contrast, the number of ␤-tubulin-positive cells was significantly reduced on the experimental side (Ϫ23.01 Ϯ 11.36%; n ϭ 7 of 10; p Ͻ 0.001) (Figs. 1 J, K, 2I) and not with control siRNA construct (ϩ1.32 Ϯ 5.65%; n ϭ 10 of 10). This suggested that suppressing RGMa function reduced neuronal differentiation. To determine whether the decrease of BrdU-labeled cells or ␤-tubulinpositive cells induced by RGMa siRNA could be attributable to increase apoptosis , we coelectroporated RGMa siRNA with the baculovirus p35, a general caspase inhibitor (Thibert et al., 2003) . In this case, a comparable decrease in the number of ␤-tubulin-positive cells (Ϫ20.30 Ϯ 2.03% reduction; n ϭ 5 of 7; p Ͻ 0.0001) (Figs. 1 L, 2I) was observed, whereas proliferation was unchanged (ϩ01.74 Ϯ 3.84%; n ϭ 7 of 8) (Fig. 2 H) . In the midbrain and hindbrain, many transcription factors or secreted molecules define the territories and polarity along the anteroposterior and dorsoventral axis, such as Pax6 (paired box gene 6), En-2 (engrailed 2), Wnt1 (wingless), ephrin-A2, and Shh (sonic hedgehog) (Nakamura, 2001) . RGMa or RGMa siRNA overexpression did not affect the expression pattern of these genes, suggesting that RGMa does not affect cell proliferation and differentiation by altering the pattern of cell fate specification in the neural tube (data not shown).
RGMa regulates neuronal differentiation through its receptor neogenin
Because the RGMa receptor neogenin is expressed in the neuroepithelium and postmitotic cells of early chick embryos (Fig. 2 D, F ) (Matsunaga et al., 2004) , we suspected that neogenin could control neuronal differentiation. To distinguish between the proapoptotic activity of neogenin and its other possible functions, full-length neogenin was coelectroporated with p35. At 24 h after neogenin electroporation, the number of BrdU-labeled cells on the experimental and control sides were almost the same (Ϫ4.25 Ϯ 3.36%; n ϭ 4 of 4) (Fig.  2 A-C) , showing that neogenin did not influence cell proliferation. However, the number of ␤-tubulin-positive cells was increased on the experimental side (ϩ27.89 Ϯ 8.80%; n ϭ 5 of 6), indicating that neogenin induced neuronal differentiation (Fig. 2 E, I ). To determine whether neogenin mediates the neuronal differentiation-promoting activity of RGMa, we performed double electroporation of RGMa with neogenin siRNA. This siRNA construct repressed endogenous neogenin expression (n ϭ 3 of 5) (Fig. 2 F) . Whereas the number of ␤-tubulinpositive cells was increased by RGMa, coelectroporation of neogenin siRNA suppressed this effect (ϩ1.28 Ϯ 8.73%; n ϭ 5 of 5) (Fig. 2G,I ). Neogenin siRNA alone did not have any effect (ϩ0.71 Ϯ 3.09%; n ϭ 7 of 7) (Fig. 2 I) . These results suggest that RGMa promotes neuronal differentiation through neogenin signaling.
RGMa regulates topographic retinotectal projection in chick embryos
By E9.5 (HH36), after retinal axons started to enter the tectum, RGMa is expressed in the tectum according to a low-anterior and high-posterior gradient as reported previously (Monnier et al., 2002) . RGMa expression was particularly strong in the ventricular zone and in layers vi and viii (LaVail and Cowan, 1971) but was not expressed in the stratum opticum and superficial layers of the tectum, in which retinal axons project at later stages (data not shown).
To study the possible role of RGMa in guiding retinotectal axons (Monnier et al., 2002) , RCASBP(B)-RGMa expression vectors were electroporated in the mesencephalon at HH10 (E1.5) (Fig. 3A) , and the retinotectal projection was analyzed at E17-E18. RGMa overexpression only transiently affects cell proliferation (this study) and apoptosis . Accordingly, the size of the tectum was similar on the experimental and control side. In addition, RGMa overexpression did not alter the gross histology and anteroposterior polarity of the tectum, in particular the expression of En-2 (data not shown) or ephrin-A2 (n ϭ 3 of 3) (Fig. 3B) . At E17, retinal axons should have formed terminal arbors [terminal zone (TZ)], and overshooting axons and ectopic branches that form during normal development should have been eliminated (Nakamura and O'Leary, 1989; Yates et al., 2001) . In control embryos [RCASBP(B)-AP], almost all labeled axons from the dorsotemporal quadrant of the retina have their TZ in the anteroventral tectum (n ϭ 5 of 5) (Figs. 3C, 4F ). In contrast, in RGMa electroporated embryos, we could detect overshooting axons passing beside their TZ (n ϭ 15 of 27) (Figs. 3 D, E, 4F) . In one case, many retinal axons projected behind their TZ, but some made a U-turn and reached their TZ (Fig. 3D) . In normal tectum, retinal axons arborize in the superficial layer [above layer g of stratum griseum et fibrosum superficiale (SGFS) or layer viii] (LaVail and Cowan, 1971) . In RGMa electroporated tectum, layers developed normally, but ectopic DiI-labeled retinal fibers penetrated into deeper layers (Figs. 3F, 4F) . In situ hybridization for RGMa performed on tectum slices of RGMa electroporated embryos revealed that DiI-labeled axons were surrounding regions with high level of RGMa expression (Fig. 3 F, G) . Similar observations were made on tectum sections labeled with anti-gag antibodies: DiI-labeled axons avoid regions of high gag expression level (Fig. 3H ). This suggests that retinal axons avoid tectum domains expressing high levels of RGMa, as expected from its repulsive action in vitro.
We next performed loss-of-function experiments of RGMa using retroviral vectors encoding two distinct RGMa siRNAs (RGMa siRNA and siRNA-2). These RGMa siRNA expression constructs strongly repressed endogenous RGMa expression (n ϭ 3 of 3 for each siRNA) (Fig.  4 A, B,D ) . In embryos electroporated with RCASBP(B)-control siRNA, the retinotectal projection developed normally (n ϭ 8 of 8) (Fig. 4 F) . In RCASBP(B)-RGMa siRNA electroporated embryos, temporal retinal axons focused into TZ as in control embryos, but many axons projected to ectopic positions posterior to their TZ proper (n ϭ 4 of 18) (Fig. 4C,F ) . However, these ectopic retinal axons still innervated and arborized into normal recipient layers (SGSF) (Fig. 4 C) . Similar results were obtained with RCASBP(B)-RGMa siRNA-2 construct (Fig. 4E,F) .
Discussion
RGMa regulates neuronal differentiation
In this study, gain-and loss-of-function experiments revealed that RGMa promotes neuronal differentiation, whereas RGMa siRNA represses it. In the developing midbrain and hindbrain, RGMa expression precedes the birth of the first neurons, suggesting that RGMa may control the timing of neuronal differentiation. Neogenin is a receptor for RGMa in axon guidance and cell survival . We showed here that neogenin overexpression promotes neural differentiation and that neogenin siRNA blocked the neuronal differentiation-promoting activity of RGMa. Overall, this suggests that RGMa controls neuronal differentiation through neogenin signaling. Because recent data suggest that RGMa is also a bone morphogenetic protein (BMP) coreceptor (Babitt et al., 2005) , a perturbation of BMP signaling may also contribute to the observed phenotypes. The function of RGMa in cell differentiation/proliferation and survival could explain the neural tube closure defects observed in RGMa knock-out mice (Niederkofler et al., 2004) .
A second RGM molecule, RGMb, is expressed in the nervous system in a complementary pattern to RGMa in mice (Niederkofler et al., 2004; Oldekamp et al., 2004; Schmidtmer and Engelkamp, 2004) and chick embryos (E. Matsunaga and A. Chédotal, unpublished data) . We found that, although RGMb, like RGMa, blocks the neogenin proapoptotic activity (Matsunaga and Chédotal, unpublished data), it does not affect cell proliferation or neuronal differentiation. This result suggests that RGMa and RGMb have distinct function in the neural tube and that the observed defects are specific for RGMa.
RGMa is involves in topographic retinotectal projection in chick embryos
The targeting of temporal retinal axons is perturbed in embryos overexpressing RGMa in the optic tectum. Although many retinal fibers still project to their appropriate TZ, overshooting axons remained and the trajectory of retinal axons is severely perturbed, suggesting an aberrant homing. Interestingly, the perturbation of the layer-specific expression of RGMa appears to induce an ectopic retinal axon extension or branching into deeper layers. In addition, loss-of-function experiments with two distinct RGMa siRNA constructs also revealed that many axons projected and arborized at wrong positions in the tectum. These results indicate that RGMa, in addition to control the development of the retinotectal projection along the tectum rostrocaudal axis, may be involved in axonal pruning and the layer-specific arborization of retinal axons possibly by steering them away from tectal layers expressing RGMa. It will be important to study possible direct or indirect interactions between ephrins-Ephs and RGM-neogenin signaling to fully understand the molecular control of retinal axons pathfinding (Frisen et al., 1998; Feldheim et al., 2000; Yamada et al., 2001; Sakurai et al., 2002) .
The phenotypic analysis of RGMa knock-out mice did not reveal any abnormal projections of visual axons (Niederkofler et al., 2004) , and this could be attributable to species differences (McLaughlin et al., 2003; Niederkofler et al., 2004) . First, RGMa is not expressed in a gradient in the superior colliculus of mouse embryos (Niederkofler et al., 2004) . Second, RGMb is expressed in the mouse superior colliculus and may also influence the development of the retinocollicular projection. Additional studies, such as the analysis of visual projections in RGMa/RGMb doublemutant mice, will be required to answer this point. It will also be important to analyze the visual projection in neogenin knock-out mice.
